Frontlight ResearchEarly access
Trial site
Bergamo
- 4running trials
- 9closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis3 trials
- Coronary artery disease2 trials
- Prostate cancer2 trials
- Stroke2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Gastric and oesophageal cancer1 trial
- Heart failure1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 38 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Terminated3 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals13 trials
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis1 recruiting
Closed trials
Completed
Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy
Terminated
Completed
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
Completed
Completed
Terminated
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026